Delivery Order SPE2DB24D2105-SPE2DB25FAQEX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,586.58 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This firm fixed-price contract was competitively awarded without set-aside designation and is set for completion by July 28, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $3,978.28 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 10, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,134.56 for 60-tablet units of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia treatment. This competitively awarded, firm fixed-price delivery order was established on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract includes no set-aside designation,...
- The Defense Logistics Agency awarded a $51,938.18 delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Multaq 400 mg tablets, a pharmaceutical product used in cardiac arrhythmia management. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 13, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $5,713.28 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This competitive award, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $3,227.88 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This non-set-aside, firm fixed-price delivery order was awarded on September 3, 2025, with an ultimate completion date of September 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,624.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitive award, which carries no set-aside designation, represents a pharmaceutical supply delivery to support federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,529.88 for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia treatment. Issued on August 8, 2025, with an ultimate completion date of August 11, 2025, this firm fixed-price contract represents a non-set-aside award made through open competition. The contractor's place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management, with a ceiling value of $1,529.88. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on August 25, 2025, with an ultimate completion date of August 26, 2025. The work is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,059.76 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count packages) under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by September 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this pharmaceutical delivery from its corporate office location. This delivery order is issued under...
- SPE2DB24D2105Indefinite Delivery Contract
- SPE2DB24D2105-SPE2DB25FAQEXDelivery Order
The Defense Logistics Agency awarded a $18,713.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia treatment. The contract was competitively awarded without set-aside designation and is scheduled for completion by September 12, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs across military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Through this contract vehicle, AmerisourceBergen serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard, maintaining its position as a primary pharmaceutical vendor within the federal supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.7k | 9/11/25 |